Bharat Rasayan
- Market cap
- ₹ 1,586 Cr.
- P/E
- 10.7x
- P/B
- 1.27x
- 52-week range
- 915.6 – 2,853
- ROE
- 13%
- ROCE
- 18%
- Dividend yield
- 0.1%
- Debt / equity
- 0
- Sector
- Fertilizers & Agrochemicals
- Industry
- Pesticides & Agrochemicals
- Listed on
- NSE, BSE
About
Bharat Rasayan Limited is an India-based company engaged in the business of manufacturing pesticides. The Company is engaged in the manufacturing and sale of technical grade pesticides and chemical intermediates. The Company’s products include Insecticides, which consist of Alphacypermethrin; Bifenthrin; Cypermethrin; Acetamiprid; Diafenthiuron; Fenvalerate; Permethrin; Thiamethoxam and others; Herbicides, which include Chlorimuron Ethyl, Diuron, Metsulfuron Methyl, Metribuzin, Pendimethalin, Sulfosulfuron and others; Fungicides, which include Myclobutanil, Tebuconazole and Difenoconazole, and Intermediates, which include Meta Phenoxy Benzaldehyde, Meta Phenoxy Benzyl Alcohol, Para Chloro Benzyl Cyanide, Cypermethrin Acid Chloride and others. The Company's plants are located at Rohtak, Haryana and Bharuch, Gujarat. Its plant at Haryana has a capacity of 4,260 metric tons (MT) per annum and has facilities for bulk packaging of formulations.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Pesticides & Agrochemicals: 33 companies →Bharat Rasayan against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)10.7 against a typical 23.6: cheaper than most peers (1st = cheapest).5th of 33
- Sales growth−10.3% against a typical −4.5% from a year earlier.20th of 31
- Profit growth−15.9% against a typical +15.2% from a year earlier.17th of 25
- Share price, 3 months−25.9% against a typical −15.5%.29th of 32
- Size₹ 1,586.2 Cr. market value against a typical ₹ 883.3 Cr. (1st = largest).11th of 31
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
High safety
Rated AA- by CARE- No warnings from the agency.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CARE | CARE AA- | Stable | 18 Dec 2025 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 18 Dec 2025 | Reaffirmed | CARE AA- | — | CARE | ₹ 250 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 13 Aug 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters |
| 26 May 2026 | Financial Results/Dividend/Other business matters | To consider and approve the audited financial results for the year ended March 31, 2026, dividend and other business matters |
| 12 Feb 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2025 and other business matters |
| 11 Nov 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2025 and other business matters |
| 24 Oct 2025 | Bonus | To consider Bonus Issue & Stock Split |
| 12 Aug 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2025 and other business matters |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 263 | 233 | 310 | 282 | 328 | 256 | 307 | 377 | 286 | 270 | 308 | 338 |
| Expenses | 248 | 205 | 240 | 244 | 273 | 215 | 266 | 304 | 253 | 228 | 258 | 287 |
| Operating Profit | 15 | 28 | 69 | 38 | 55 | 42 | 40 | 73 | 33 | 43 | 50 | 51 |
| OPM % | 6% | 12% | 22% | 14% | 17% | 16% | 13% | 19% | 12% | 16% | 16% | 15% |
| Other Income | 4 | 4 | 11 | 6 | 7 | 7 | 6 | −8 | 9 | 11 | 10 | 6 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 6 | 7 | 6 | 6 | 6 | 7 | 7 | 6 | 6 | 7 | 7 | 7 |
| Profit before tax | 12 | 24 | 73 | 37 | 54 | 41 | 38 | 58 | 35 | 46 | 52 | 48 |
| Tax % | 34% | 27% | 23% | 27% | 25% | 27% | 25% | 25% | 24% | 26% | 25% | 24% |
| Net Profit | 8 | 17 | 56 | 27 | 40 | 30 | 28 | 44 | 26 | 34 | 39 | 37 |
| EPS in Rs | 4.63 | 10.41 | 33.68 | 16.14 | 24.19 | 17.89 | 17.14 | 26.3 | 15.76 | 20.45 | 23.54 | 22.04 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 11%
- 5 Years
- 3%
- 3 Years
- 0%
- TTM
- −5%
- 10 Years
- 17%
- 5 Years
- −1%
- 3 Years
- 5%
- TTM
- −9%
- 10 Years
- 13%
- 5 Years
- −16%
- 3 Years
- −16%
- TTM
- —
- 10 Years
- 19%
- 5 Years
- 14%
- 3 Years
- 11%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Bharat Rasayan | ₹ 945.00 | ₹ 1,586 Cr. | 10.7x | 1.3x | 13% | — |
| Asian Paints | ₹ 2,305.00 | ₹ 2,21,095 Cr. | 58.1x | 12.1x | 21.2% | 12.4% |
| Solar Industries India | ₹ 18,320.00 | ₹ 1,65,778 Cr. | 99.6x | 26.6x | 31.4% | 17.7% |
| Pidilite Industries | ₹ 1,514.00 | ₹ 1,54,107 Cr. | 64.8x | 14.7x | 23.8% | 16.9% |
| SRF | ₹ 2,309.00 | ₹ 68,444 Cr. | 44.6x | 6.1x | 13.8% | 11.6% |
| Linde India | ₹ 5,697.00 | ₹ 48,586 Cr. | 110.5x | 14.2x | 13.6% | 21.7% |
Management
- Sat Narain Gupta
- Executive Chairman of the Board, Managing Director
- Rajender Prasad Gupta
- Chief Executive Officer, Whole-Time Director
- Rakesh Kumar Verma
- Chief Financial Officer
- Nikita Chadha
- Compliance Officer, Company Secretary
- Ajay Kumar Gupta
- Whole-Time Director
- Mahabir Prasad Gupta
- Whole-Time Director
- Kamleshwar Prasad Uniyal
- Whole-Time Director
Prices are delayed and for information only. Nothing on this page is investment advice.